Literature DB >> 21253120

Malignant lymphomas: their diagnosis, treatment and prognosis.

S E O'Reilly.   

Abstract

The author of this paper reviews the diagnosis and management of malignant lymphomas, as well as the prognosis for various groups of patients.

Entities:  

Year:  1988        PMID： 21253120      PMCID： PMC2218994     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  11 in total

1.  Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.

Authors:  A Santoro; G Bonadonna; P Valagussa; R Zucali; S Viviani; F Villani; A M Pagnoni; V Bonfante; R Musumeci; F Crippa
Journal:  J Clin Oncol       Date:  1987-01       Impact factor: 44.544

2.  Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.

Authors:  G Bonadonna; P Valagussa; A Santoro
Journal:  Ann Intern Med       Date:  1986-06       Impact factor: 25.391

3.  Report of the Committee on Hodgkin's Disease Staging Classification.

Authors:  P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

4.  Combination chemotherapy in the treatment of advanced Hodgkin's disease.

Authors:  V T Devita; A A Serpick; P P Carbone
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

5.  New approaches to the classification of the lymphomata.

Authors:  R J Lukes; R D Collins
Journal:  Br J Cancer Suppl       Date:  1975-03

6.  Long-term remission durability and functional status of patients treated for diffuse histiocytic lymphoma with the CHOP regimen.

Authors:  J O Armitage; M A Fyfe; J Lewis
Journal:  J Clin Oncol       Date:  1984-08       Impact factor: 44.544

7.  MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma.

Authors:  P Klimo; J M Connors
Journal:  Ann Intern Med       Date:  1985-05       Impact factor: 25.391

8.  Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma.

Authors:  J M Connors; P Klimo; R N Fairey; N Voss
Journal:  Ann Intern Med       Date:  1987-07       Impact factor: 25.391

9.  MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease.

Authors:  P Klimo; J M Connors
Journal:  J Clin Oncol       Date:  1985-09       Impact factor: 44.544

10.  Updated clinical experience with MACOP-B.

Authors:  P Klimo; J M Connors
Journal:  Semin Hematol       Date:  1987-04       Impact factor: 3.851
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.